Pain Catastrophizing and Routine Assessment of Patient Index Data 3(RAPID3) in Ten Categories of Rheumatology Outpatients

Arthritis, Rheumatoid Clinical Trial

Official title:

Transversal Study of Correlations Between Pain Catastrophizing Scale (PCS) and RAPID3 Score According to Ten Categories of Conditions Seen in an Outpatient Rheumatology Clinic

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03306784
• Other study ID #: RC17_0182
• Status: Completed
• Start date: July 3, 2017
• Est. completion date: January 31, 2018

Study information

• Verified date: September 2021
• Source: Nantes University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Fulfilling by all patients consequently seen by 6 rheumatologists in a same outpatient rheumatology clinic (in at least one month period) of a set of 6 questionnaires, including RAPID3 and pain catastrophizing scales.

Description:

Fulfilling by all patients (seen by 6 rheumatologists in a same outpatient rheumatology clinic from a university French hospital in at least one month period) of a set of 6 questionnaires including a RAPID3 score (Routine Assessment of Patient Index Data 3) and pain catastrophizing scale, as well as Pain detect and Hospital Anxiety and Depression scale questionnaires (HAD) , in ten predefined categories of disorders: rheumatoid arthritis; any spondyloarthritis; other inflammatory rheumatisms or systemic disorders; osteoarthritis of the upper part of the body; osteoarthritis of the lower part of the body; back pain and/or radiculalgia; bone disorders, including osteoporosis; tendinosis and other soft tissue conditions; peripheral neuropathy, including entrapment neuropathies; fibromyalgia and related conditions.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 572
• Est. completion date: January 31, 2018
• Est. primary completion date: January 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• any outpatient aged 18 or more, agreeing to fulfil the set of 6 questionnaires

• Man or woman coming to the Rheumatology Department of the Nantes University Hospital with a senior rheumatologist

Exclusion Criteria:

• Patients not fluent enough in French or suffering from neurological or psychological disorders making their responses unreliable

Related Conditions & MeSH terms

• Arthritis, Rheumatoid
• Inflammatory Rheumatisms
• Rheumatic Diseases
• Rheumatic Fever
• Spondylarthritis
• Spondyloarthritis
• Systemic Disorders

Intervention

Other:
• questionnaires
questionnaires, including RAPID3 and pain catastrophizing scales

Locations

Country	Name	City	State
France	CHU de Nantes	Nantes

Sponsors (1)

Lead Sponsor	Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Ranking of PCS scores according to the underlying disorders (10 predefined categories), and also ranking of RAPID-3 scores according to the underlying disorders (10 predefined categories).	Composite score: RAPID3 (0-30) and PCS (0-52) are widely used scales, suitable for routine fulfillment by outpatients.	At least one month for each physician, and at least 30 patients in each category (whatever the physician seen).
Secondary	Ranking of correlations between RAPID3 and Pain catastrophizing scale (PCS) (13 items) scores in the 10 subsets of categories listed above (from the strongest correlation to the lowest correlation)	RAPID3 (0-30) and PCS (0-52) are widely used scales, suitable for routine fulfillment by outpatients	At least one month for each physician, and at least 30 patients in each category (whatever the physician seen).